SMARTROUTE Trademark
Trademark Overview
On Wednesday, December 27, 2023, a trademark application was filed for SMARTROUTE with the United States Patent and Trademark Office. The USPTO has given the SMARTROUTE trademark a serial number of 79395860. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 4, 2024. This trademark is owned by Acies Bio d.o.o.. The SMARTROUTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Development and planning of manufacturing processes for the production of vitamins, food supplements for humans and animals, bio pesticides and chemicals; biotechnological and pharmaceutical research, consultancy related to biotechnology, development in the field of biotechnology and pharmacy, engineering, scientific research in the field of genetics and genetic engineering; biological cloning services; development and research in the field of microbial biotechnology; research, development and testing services in the field of biotechnology, biochemistry, microbiology and molecular science; biological research, clinical research and medical research; industry analysis and research; research and development of industrial process; chemical technological research; development of new technologies for others; product development for others; design of production methods; development of new strains for use in the chemical and pharmaceutical industry and agriculture, development of new genes, p...
General Information
| Serial Number | 79395860 |
| Word Mark | SMARTROUTE |
| Filing Date | Wednesday, December 27, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, November 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | SMART ROUTE |
| Goods and Services | Development and planning of manufacturing processes for the production of vitamins, food supplements for humans and animals, bio pesticides and chemicals; biotechnological and pharmaceutical research, consultancy related to biotechnology, development in the field of biotechnology and pharmacy, engineering, scientific research in the field of genetics and genetic engineering; biological cloning services; development and research in the field of microbial biotechnology; research, development and testing services in the field of biotechnology, biochemistry, microbiology and molecular science; biological research, clinical research and medical research; industry analysis and research; research and development of industrial process; chemical technological research; development of new technologies for others; product development for others; design of production methods; development of new strains for use in the chemical and pharmaceutical industry and agriculture, development of new genes, proteins and protein fractions for use in chemistry, pharmaceuticals, agriculture, diagnostics, medicine and industry; algorithm-supported design and development of strains and fermentation media; testing, authentication and quality control of molecules in the field of microscopy; laboratory services; vaccine development and testing; monitoring, controlling, assessing and consulting with reference to biohazards; biological, microbiological, pathogenic and viral screening and testing services; proficiency testing; collecting, maintaining and providing access to bacterial cultures and bacterial isolates for scientific and research purposes; pharmaceutical research; analysis and developments in the field of molecular biology; biomedical research services; DNA sequencing for medical research purposes; preparation of biological samples for the analysis in research laboratories; research services in the field of proteins, antibodies, microorganisms and cells; development of pharmaceutical preparations, medicines, biological molecules, stem cells, genes, vaccines, bacteria, viruses; development of final process (downstream processing) in the field of pharmacy, biotechnology, genetics, biochemistry, microbiology and molecular sciences; research services in the field of cell separation and drug purification; scientific services related to the isolation and cultivation of human tissues and cells; preparation of biological samples for research purposes. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 16, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Acies Bio d.o.o. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | SI |
Trademark Events
| Event Date | Event Description |
| Thursday, May 16, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, May 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 25, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 22, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 29, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, November 4, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 4, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, November 23, 2024 | REFUSAL PROCESSED BY IB |
